Brief: Processa Pharma Announces Prioritization On Development Of Next Gen Chemotherapies

Processa Pharmaceuticals

21/02/2023 14:26

Feb 21 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS ANNOUNCES PRIORITIZATION ON
DEVELOPMENT
OF NEXT GENERATION CHEMOTHERAPIES
    * PROCESSA PHARMACEUTICALS - FDA MEETINGS PLANNED IN 2023 TO
DISCUSS NEXT PHASES OF DEVELOPMENT, PLAN TO INCLUDE PRINCIPLES
OF PROJECT OPTIMUS, ONCOLOGY GUIDANCE
    * PROCESSA PHARMACEUTICALS INC - OPPORTUNITIES TO MONETIZE
OR
PARTNER NON-ONCOLOGY ASSETS ARE BEING EVALUATED
    * PROCESSA PHARMACEUTICALS- CO BEGUN, TO CONTINUE TO MEET
WITH
POTENTIAL LICENSING PARTNERS, AS WELL AS PURSUE OTHER OPTIONS TO
MONETIZE PCS12852 AND PCS499

Source text for Eikon:  ID:nGNX1y0g9q 
Further company coverage:  PCSA.O 
 ((Reuters.Briefs@thomsonreuters.com;))